This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A warning letter posted Tuesday by the Food and Drug ...
Life-changing CGM system indicated for persons age 2 years and older, now available for wear on back of the upper arm, giving patients more options EDINBURGH, Scotland, June 9, 2020 /PRNewswire/ -- ...
BURNABY, BC, April 16, 2021 /CNW/ - Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), is pleased to see that the governments of Saskatchewan and Manitoba both ...
When it comes to the diabetes space, Dexcom is one of the heavy hitters. Its work in the continuous glucose monitoring space has put it on the map. In 2018, its Dexcom G6, an integrated continuous ...
DexCom, Inc. DXCM recently announced the first-ever registry committed toward keeping a track on the outcomes of patients and healthcare professionals using Continuous Glucose Monitoring (CGM) in ...
Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...
The FDA on Tuesday approved the use of a professional continuous glucose monitoring system from Dexcom, according to a press release from the company. Glucose measures are tracked for 10 days with the ...
After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...
ISTANBUL, Sept. 29, 2020 /PRNewswire/ -- DexCom, Inc. (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today market entry into Turkey, with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback